Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients With Normalized Cancer Therapy Related Cardiac Dysfunction: The STOP-MED CTRCD Trial

NCT06183437 is registered in ClinicalTrials.gov with Dinesh Thavendiranathan as lead sponsor.

NCT NCT06183437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06183437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients With Normalized Cancer Therapy Related Cardiac Dysfunction: The STOP-MED CTRCD Trial
Lead sponsor
Dinesh Thavendiranathan
Phase
Phase 4
Overall status
Recruiting
Start date
March 4, 2024
Completion date
December 31, 2031
Enrollment
335 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastics toxicity, cancer, cardiac toxicity, cardiotoxicity, heart failure